Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica A Slavin

Showing results (111-120 of 281) with videos related to

Pageof 29
Sort By:
Leukemia & Lymphoma|January 12, 2019
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemiaBenjamin W Teh, William Chui, Sasanka Handunnetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2017
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncologyChristopher C Blyth, Gabrielle M Haeusler, Brendan J McMullan, et al.
The Lancet. Infectious Diseases|August 5, 2017
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancerA L Colombo, J N de Almeida Júnior, Monica A Slavin, et al.
Leukemia & Lymphoma|April 6, 2019
FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in AustraliaAbby P Douglas, Karin A Thursky, Leon J Worth, et al.
Antimicrobial Resistance and Infection Control|June 3, 2015
The impact of antimicrobial allergy labels on antimicrobial usage in cancer patientsJason A Trubiano, Vivian K Leung, Man Y Chu, et al.
Plos One|September 25, 2014
Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processingMichelle R Ananda-Rajah, David Martinez, Monica A Slavin, et al.
BMJ Open|August 1, 2025
Estimating the prevalence of key healthcare-associated and opportunistic infections in Australian transplant and cancer populations: protocol for the PROSPER point prevalence studyPriya Garg, Nikhil Singh, Alice J Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 9, 2020
The QuantiFERON Monitor<sup>®</sup> assay is predictive of infection post allogeneic hematopoietic cell transplantationAbby P Douglas, Lijia Yu, Vijaya Sundararajan, et al.
Internal Medicine Journal|December 23, 2021
Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatmentShio Yen Tio, Eloise Williams, Leon J Worth, et al.
Internal Medicine Journal|September 20, 2018
Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologistsAbby P Douglas, Karin A Thursky, Leon J Worth, et al.
Pageof 29

Showing results (111-120 of 281) with videos related to

Sort By:
Pageof 29
Leukemia & Lymphoma|January 12, 2019
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemiaBenjamin W Teh, William Chui, Sasanka Handunnetti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 30, 2017
Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncologyChristopher C Blyth, Gabrielle M Haeusler, Brendan J McMullan, et al.
The Lancet. Infectious Diseases|August 5, 2017
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancerA L Colombo, J N de Almeida Júnior, Monica A Slavin, et al.
Leukemia & Lymphoma|April 6, 2019
FDG-PET/CT in managing infection in patients with hematological malignancy: clinician knowledge and experience in AustraliaAbby P Douglas, Karin A Thursky, Leon J Worth, et al.
Antimicrobial Resistance and Infection Control|June 3, 2015
The impact of antimicrobial allergy labels on antimicrobial usage in cancer patientsJason A Trubiano, Vivian K Leung, Man Y Chu, et al.
Plos One|September 25, 2014
Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processingMichelle R Ananda-Rajah, David Martinez, Monica A Slavin, et al.
BMJ Open|August 1, 2025
Estimating the prevalence of key healthcare-associated and opportunistic infections in Australian transplant and cancer populations: protocol for the PROSPER point prevalence studyPriya Garg, Nikhil Singh, Alice J Liu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 9, 2020
The QuantiFERON Monitor<sup>®</sup> assay is predictive of infection post allogeneic hematopoietic cell transplantationAbby P Douglas, Lijia Yu, Vijaya Sundararajan, et al.
Internal Medicine Journal|December 23, 2021
Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatmentShio Yen Tio, Eloise Williams, Leon J Worth, et al.
Internal Medicine Journal|September 20, 2018
Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologistsAbby P Douglas, Karin A Thursky, Leon J Worth, et al.
Pageof 29